Advances in understanding the role of interleukins in pulmonary fibrosis (Review)
- Authors:
- Yuqing He
- Xuebin Shen
- Kefeng Zhai
- Sihui Nian
-
Affiliations: School of Pharmacy, Wannan Medical College, Wuhu, Anhui 241002, P.R. China, School of Biological and Food Engineering, Engineering Research Center for Development and High Value Utilization of Genuine Medicinal Materials in North Anhui Province, Suzhou University, Suzhou, Anhui 234000, P.R. China - Published online on: November 28, 2024 https://doi.org/10.3892/etm.2024.12775
- Article Number: 25
-
Copyright: © He et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
Ding DL, Shen XB, Yu LZ, Zheng YY, Liu Y, Wang W, Liu L, Zhao ZT, Nian SH and Liu LM: Timosaponin BII inhibits TGF-β mediated epithelial-mesenchymal transition through Smad-dependent pathway during pulmonary fibrosis. Phytother Res. 37:2787–2799. 2023.PubMed/NCBI View Article : Google Scholar | |
Zhao T, Zhou Z, Wan H, Feng T, Hu X, Li X, Zhao S, Li H, Hou J, Li W, et al: Otilonium bromide ameliorates pulmonary fibrosis in mice through activating phosphatase PPM1A. Acta Pharmacol Sin: August 19, 2024 (Epub ahead of print). | |
Tu JY, Chen XY, Li CY, Liu CF, Huang YB, Wang X, Liang H and Yuan XL: Nintedanib mitigates radiation-induced pulmonary fibrosis by suppressing epithelial cell inflammatory response and inhibiting fibroblast-to-myofibroblast transition. Int J Biol Sci. 20:3353–3371. 2024.PubMed/NCBI View Article : Google Scholar | |
Confalonieri P, Volpe MC, Jacob J, Maiocchi S, Salton F, Ruaro B, Confalonieri M and Braga L: Regeneration or repair? The role of alveolar epithelial cells in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Cells. 11(2095)2022.PubMed/NCBI View Article : Google Scholar | |
Kinoshita T and Goto T: Molecular mechanisms of pulmonary fibrogenesis and its progression to lung cancer: A review. Int J Mol Sci. 20(1461)2019.PubMed/NCBI View Article : Google Scholar | |
Pu Z, Sui B, Wang X, Wang W, Li L and Xie H: The effects and mechanisms of the anti-COVID-19 traditional Chinese medicine, Dehydroandrographolide from Andrographis paniculata (Burm.f.) Wall, on acute lung injury by the inhibition of NLRP3-mediated pyroptosis. Phytomedicine. 114(154753)2023.PubMed/NCBI View Article : Google Scholar | |
Yang H, Hua C, Yang X, Fan X, Song H, Peng L and Ci X: Pterostilbene prevents LPS-induced early pulmonary fibrosis by suppressing oxidative stress, inflammation and apoptosis in vivo. Food Funct. 11:4471–4484. 2020.PubMed/NCBI View Article : Google Scholar | |
Otoupalova E, Smith S, Cheng GJ and Thannickal VJ: Oxidative stress in pulmonary fibrosis. Compr Physiol. 10:509–547. 2020.PubMed/NCBI View Article : Google Scholar | |
Valenca SS, Dong BE, Gordon EM, Sun RC and Waters CM: ASK1 regulates bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 66:484–496. 2022.PubMed/NCBI View Article : Google Scholar | |
Tremayne P and John Clark S: Idiopathic pulmonary fibrosis: A more common condition than you may think. Br J Nurs. 30:359–366. 2021.PubMed/NCBI View Article : Google Scholar | |
Hoyer N, Prior TS, Bendstrup E, Wilcke T and Shaker SB: Risk factors for diagnostic delay in idiopathic pulmonary fibrosis. Respir Res. 20(103)2019.PubMed/NCBI View Article : Google Scholar | |
Maher TM, Bendstrup E, Dron L, Langley J, Smith G, Khalid JM, Patel H and Kreuter M: Global incidence and prevalence of idiopathic pulmonary fibrosis. Respir Res. 22(197)2021.PubMed/NCBI View Article : Google Scholar | |
Glassberg MK: Overview of idiopathic pulmonary fibrosis, evidence-based guidelines, and recent developments in the treatment landscape. Am J Manag Care. 25 (11 Suppl):S195–S203. 2019.PubMed/NCBI | |
Agostini C and Gurrieri C: Chemokine/cytokine cocktail in idiopathic pulmonary fibrosis. Proc Am Thorac Soc. 3:357–363. 2006.PubMed/NCBI View Article : Google Scholar | |
Li H, Li Q and Hao Z, Zhang L, Zheng X, Zhu L, Huo Y, Tian H, He L and Hao Z: A recombinant IL-1β vaccine attenuates bleomycin-induced pulmonary fibrosis in mice. Vaccine. 42:3774–3788. 2024.PubMed/NCBI View Article : Google Scholar | |
Park SJ, Ryu HW, Kim JH, Hahn HJ, Jang HJ, Ko SK, Oh SR and Lee HJ: Daphnetin alleviates bleomycin-induced pulmonary fibrosis through inhibition of epithelial-to-mesenchymal transition and IL-17A. Cells. 12(2795)2023.PubMed/NCBI View Article : Google Scholar | |
Xu X, Dai W and Li C: Interleukins in the treatment of melanoma. Chin Med J (Engl). 135:393–399. 2022.PubMed/NCBI View Article : Google Scholar | |
Gritsenko A, Diaz-Pino R and López-Castejón G: NLRP3 inflammasome triggers interleukin-37 release from human monocytes. Eur J Immunol. 52:1141–1157. 2022.PubMed/NCBI View Article : Google Scholar | |
Fukaura R and Akiyama M: Targeting IL-36 in inflammatory skin diseases. Biodrugs. 37:279–293. 2023.PubMed/NCBI View Article : Google Scholar | |
Bequignon E, Mangin D, Bécaud J, Pasquier J, Angely C, Bottier M, Escudier E, Isabey D, Filoche M, Louis B, et al: Pathogenesis of chronic rhinosinusitis with nasal polyps: Role of IL-6 in airway epithelial cell dysfunction. J Transl Med. 18(136)2020.PubMed/NCBI View Article : Google Scholar | |
Mesas-Fernández A, Bodner E, Hilke FJ, Meier K, Ghoreschi K and Solimani F: Interleukin-21 in autoimmune and inflammatory skin diseases. Eur J Immunol. 53(e2250075)2023.PubMed/NCBI View Article : Google Scholar | |
Akdis M, Burgler S, Crameri R, Eiwegger T, Fujita H, Gomez E, Klunker S, Meyer N, O'Mahony L, Palomares O, et al: Interleukins, from 1 to 37, and interferon-γ: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 127:701–721.e1-e70. 2011.PubMed/NCBI View Article : Google Scholar | |
Li Y, Yin H, Yuan H, Wang E, Wang C, Li H, Geng X, Zhang Y and Bai J: IL-10 deficiency aggravates cell senescence and accelerates BLM-induced pulmonary fibrosis in aged mice via PTEN/AKT/ERK pathway. BMC Pulm Med. 24(443)2024.PubMed/NCBI View Article : Google Scholar | |
Fattakhov N, Ngo A, Torices S, Joseph JA, Okoro A, Moore C, Naranjo O, Becker S and Toborek M: Cenicriviroc prevents dysregulation of astrocyte/endothelial cross talk induced by ischemia and HIV-1 via inhibiting the NLRP3 inflammasome and pyroptosis. Am J Physiol Cell Physiol. 326:C487–C504. 2024.PubMed/NCBI View Article : Google Scholar | |
Chen P, Zhou J, Ruan AM, Ma YF and Wang QF: Paeoniflorin, the Main monomer component of paeonia lactiflora, exhibits anti-inflammatory properties in osteoarthritis synovial inflammation. Chin J Integr Med. 30:433–442. 2024.PubMed/NCBI View Article : Google Scholar | |
Xiong Y, Cui X, Zhou Y, Chai G, Jiang X, Ge G, Wang Y, Sun H, Che H, Nie Y and Zhao P: Dehydrocostus lactone inhibits BLM-induced pulmonary fibrosis and inflammation in mice via the JNK and p38 MAPK-mediated NF-κB signaling pathways. Int Immunopharmacol. 98(107780)2021.PubMed/NCBI View Article : Google Scholar | |
Yan L, Hou C, Liu J, Wang Y, Zeng C, Yu J, Zhou T, Zhou Q, Duan S and Xiong W: Local administration of liposomal-based Plekhf1 gene therapy attenuates pulmonary fibrosis by modulating macrophage polarization. Sci China Life Sci. 66:2571–2586. 2023.PubMed/NCBI View Article : Google Scholar | |
Zhang LM, Zhang Y, Fei C, Zhang J, Wang L, Yi ZW and Gao G: Neutralization of IL-18 by IL-18 binding protein ameliorates bleomycin-induced pulmonary fibrosis via inhibition of epithelial-mesenchymal transition. Biochem Biophys Res Commun. 508:660–666. 2019.PubMed/NCBI View Article : Google Scholar | |
Xu X, Luo S, Li B, Dai H and Zhang J: IL-25 contributes to lung fibrosis by directly acting on alveolar epithelial cells and fibroblasts. Exp Biol Med (Maywood). 244:770–780. 2019.PubMed/NCBI View Article : Google Scholar | |
Nie YJ, Wu SH, Xuan YH and Yan G: Role of IL-17 family cytokines in the progression of IPF from inflammation to fibrosis. Mil Med Res. 9(21)2022.PubMed/NCBI View Article : Google Scholar | |
Boersma B, Jiskoot W, Lowe P and Bourquin C: The interleukin-1 cytokine family members: Role in cancer pathogenesis and potential therapeutic applications in cancer immunotherapy. Cytokine Growth Factor Rev. 62:1–14. 2021.PubMed/NCBI View Article : Google Scholar | |
Garlanda C and Mantovani A: Interleukin-1 in tumor progression, therapy, and prevention. Cancer Cell. 39:1023–1027. 2021.PubMed/NCBI View Article : Google Scholar | |
Dinarello CA: Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood. 117:3720–3732. 2011.PubMed/NCBI View Article : Google Scholar | |
Dinarello CA: Interleukin-1. Cytokine Growth Factor Rev. 8:253–265. 1997.PubMed/NCBI View Article : Google Scholar | |
Calverley PM, Sethi S, Dawson M, Ward CK, Finch DK, Penney M, Newbold P and van der Merwe R: A randomised, placebo-controlled trial of anti-interleukin-1 receptor 1 monoclonal antibody MEDI8968 in chronic obstructive pulmonary disease. Respir Res. 18(153)2017.PubMed/NCBI View Article : Google Scholar | |
Grönberg C, Rattik S, Tran-Manh C, Zhou X, Rius Rigau A, Li YN, Györfi AH, Dickel N, Kunz M, Kreuter A, et al: Combined inhibition of IL-1, IL-33 and IL-36 signalling by targeting IL1RAP ameliorates skin and lung fibrosis in preclinical models of systemic sclerosis. Ann Rheum Dis. 83:1156–1168. 2024.PubMed/NCBI View Article : Google Scholar | |
Zhang YX, Zhang XT, Li HJ, Zhou TF, Zhou AC, Zhong ZL, Liu YH, Yuan LL, Zhu HY, Luan D and Tong JC: Antidepressant-like effects of helicid on a chronic unpredictable mild stress-induced depression rat model: Inhibiting the IKK/IκBα/NF-κB pathway through NCALD to reduce inflammation. Int Immunopharmacol. 93(107165)2021.PubMed/NCBI View Article : Google Scholar | |
Li W, Zhao X, Yu TT, Hao W and Wang GG: Knockout of PKC θ gene attenuates oleic acid-induced acute lung injury via reduction of inflammation and oxidative stress. Iran J Basic Med Sci. 24:986–991. 2021.PubMed/NCBI View Article : Google Scholar | |
Witzenrath M and Kuebler WM: The lung-brain axis in ventilator-induced brain injury: Enter IL-6. Am J Respir Cell Mol Biol. 65:339–340. 2021.PubMed/NCBI View Article : Google Scholar | |
Jones BE, Maerz MD and Buckner JH: IL-6: A cytokine at the crossroads of autoimmunity. Curr Opin Immunol. 55:9–14. 2018.PubMed/NCBI View Article : Google Scholar | |
Le TTT, Karmouty-Quintana H, Melicoff E, Le TTT, Weng T, Chen NY, Pedroza M, Zhou Y, Davies J, Philip K, et al: Blockade of IL-6 trans signaling attenuates pulmonary fibrosis. J Immunol. 193:3755–3768. 2014.PubMed/NCBI View Article : Google Scholar | |
Zhao FZ, Sang XQ, Zhu Y and Yang J: Effect and mechanism of IL-6 induced by M2 macrophages on the lung fibroblasts activation. Acta Pharmaceutica Sinica. 55:892–897. 2020. | |
Yang LB, Herrera J, Gilbertsen AJ, Xia H, Smith K, Benyumov A, Bitterman PB and Henke CA: IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity. Am J Physiol Lung Cell Mol Physiol. 314:L127–L136. 2018.PubMed/NCBI View Article : Google Scholar | |
Shochet GE, Brook E, Bardenstein-Wald B and Shitrit D: TGF-β pathway activation by idiopathic pulmonary fibrosis (IPF) fibroblast derived soluble factors is mediated by IL-6 trans-signaling. Respir Res. 12(56)2020.PubMed/NCBI View Article : Google Scholar | |
Liu Y, Lu F, Kang L, Wang Z and Wang Y: Pirfenidone attenuates bleomycin-induced pulmonary fibrosis in mice by regulating Nrf2/Bach1 equilibrium. BMC Pulm Med. 17(63)2017.PubMed/NCBI View Article : Google Scholar | |
Cebi M and Yilmaz Y: Immune system dysregulation in the pathogenesis of non-alcoholic steatohepatitis: Unveiling the critical role of T and B lymphocytes. Front Immunol. 15(1445634)2024.PubMed/NCBI View Article : Google Scholar | |
Read J, Reid AT, Thomson C, Plit M, Mejia R, Knight DA, Lize M, Kasmi KE, Grainge CL, Stahl H and Schuliga M: Alveolar epithelial cells of lung fibrosis patients are susceptible to severe virus-induced injury. Clin Sci (Lond). 138:537–554. 2024.PubMed/NCBI View Article : Google Scholar | |
Jøntvedt Jørgensen M, Holter JC, Christensen EE, Schjalm C, Tonby K, Pischke SE, Jenum S, Skeie LG, Nur S, Lind A, et al: Increased interleukin-6 and macrophage chemoattractant protein-1 are associated with respiratory failure in COVID-19. Sci Rep. 10(21697)2020.PubMed/NCBI View Article : Google Scholar | |
Khanna D, Lin CJF, Furst DE, Goldin J, Kim G, Kuwana M, Allanore Y, Matucci-Cerinic M, Distler O, Shima Y, et al: Tocilizumab in systemic sclerosis: A randomised, double-blind, placebo-controlled, phase 3 trial. Lancet Respir Med. 8:963–974. 2020.PubMed/NCBI View Article : Google Scholar | |
Sagaram M, Frimodig J, Jayanty D, Hu H, Royer AJ, Bruner R, Kong M, Schwandt ML and Vatsalya V: One-month assessment of Th-cell axis related inflammatory cytokines, IL-17 and IL-22 and their role in alcohol-associated liver disease. Front Immunol. 14(1202267)2023.PubMed/NCBI View Article : Google Scholar | |
Kosmopoulos M, Christofides A, Drekolias D, Zavras PD, Gargalionis AN and Piperi C: Critical role of IL-8 targeting in gliomas. Curr Med Chem. 25:1954–1967. 2018.PubMed/NCBI View Article : Google Scholar | |
W.Y. B: Changes of IL-2R, IL-6, IL-8, and TNF-α in diffuse large B-cell lymphoma and their significance. J Clin Hematol. 36:33–38. 2023. | |
Papiris SA, Tomos IP, Karakatsani A, Spathis A, Korbila I, Analitis A, Kolilekas L, Kagouridis K, Loukides S, Karakitsos P and Manali ED: High levels of IL-6 and IL-8 characterize early-on idiopathic pulmonary fibrosis acute exacerbations. Cytokine. 102:168–172. 2018.PubMed/NCBI View Article : Google Scholar | |
Yang L, Xia H, Gilbertsen A, Smith K, Racila E, Bitterman PB and Henke CA: IL-8 concurrently promotes idiopathic pulmonary fibrosis mesenchymal progenitor cell senescence and PD-L1 expression enabling escape from immune cell surveillance. Am J Physiol Lung Cell Mol Physiol. 324:L849–L862. 2023.PubMed/NCBI View Article : Google Scholar | |
Li Y, Su G, Zhong Y, Xiong Z, Huang T, Quan J, Huang J, Wen X, Luo C, Zheng W, et al: HB-EGF-induced IL-8 secretion from airway epithelium leads to lung fibroblast proliferation and migration. BMC Pulm Med. 21(347)2021.PubMed/NCBI View Article : Google Scholar | |
Kato A: Immunopathology of chronic rhinosinusitis. Allergol Int. 64:121–130. 2015.PubMed/NCBI View Article : Google Scholar | |
Moonwiriyakit A, Yimnual C, Noitem R, Dinsuwannakol S, Sontikun J, Kaewin S, Worakajit N, Soontornniyomkij V and Muanprasat C: GPR120/FFAR4 stimulation attenuates airway remodeling and suppresses IL-4- and IL-13-induced airway epithelial injury via inhibition of STAT6 and Akt. Biomed Pharmacother. 168(115774)2023.PubMed/NCBI View Article : Google Scholar | |
Iwaszko M, Biały S and Bogunia-Kubik K: Significance of interleukin (IL)-4 and IL-13 in inflammatory arthritis. Cells. 10(3000)2021.PubMed/NCBI View Article : Google Scholar | |
Husna SMN, Shukri NM, Ashari NSM and Wong KK: IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma. PeerJ. 10(e13444)2022.PubMed/NCBI View Article : Google Scholar | |
Bonser LR, Eckalbar WL, Rodriguez L, Shen J, Koh KD, Ghias K, Zlock LT, Christenson S, Woodruff PG, Finkbeiner WE and Erle DJ: The type 2 asthma mediator IL-13 inhibits severe acute respiratory syndrome coronavirus 2 infection of bronchial epithelium. Am J Respir Cell Mol Biol. 66:391–401. 2022.PubMed/NCBI View Article : Google Scholar | |
Le Floc'h A, Allinne J, Nagashima K, Scott G, Birchard D, Asrat S, Bai Y, Lim WK, Martin J, Huang T, et al: Dual blockade of IL-4 and IL-13 with dupilumab, an IL-4Rα antibody, is required to broadly inhibit type 2 inflammation. Allergy. 75:1188–1204. 2020.PubMed/NCBI View Article : Google Scholar | |
Passalacqua G, Mincarini M, Colombo D, Troisi G, Ferrari M, Bagnasco D, Balbi F, Riccio A and Canonica GW: IL-13 and idiopathic pulmonary fibrosis: Possible links and new therapeutic strategies. Pulm Pharmacol Ther. 45:95–100. 2017.PubMed/NCBI View Article : Google Scholar | |
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, et al: Dupilumab for COPD with type 2 inflammation indicated by eosinophil counts. N Engl J Med. 389:205–214. 2023.PubMed/NCBI View Article : Google Scholar | |
Maher TM, Costabel U, Glassberg MK, Kondoh Y, Ogura T, Scholand MB, Kardatzke D, Howard M, Olsson J, Neighbors M, et al: Phase 2 trial to assess lebrikizumab in patients with idiopathic pulmonary fibrosis. Eur Respir J. 57(1902442)2021.PubMed/NCBI View Article : Google Scholar | |
Shaikh SB, Prabhu A and Bhandary YP: Interleukin-17A: A potential therapeutic target in chronic lung diseases. Endocr Metab Immune Disord Drug Targets. 19:921–928. 2019.PubMed/NCBI View Article : Google Scholar | |
Berry SPDG, Dossou C, Kashif A, Sharifinejad N, Azizi G, Hamedifar H, Sabzvari A and Zian Z: The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases. Int Immunopharmacol. 102(108402)2022.PubMed/NCBI View Article : Google Scholar | |
Yang Z, Zhang J, Zhu Y, Zhang C, Li G, Liu S, Du J, Han Y and You B: IL-17A induces valvular endothelial inflammation and aggravates calcific aortic valve disease. Biochem Biophys Res Commun. 672:145–153. 2023.PubMed/NCBI View Article : Google Scholar | |
Luo J, An X, Yao Y, Erb C, Ferguson A, Kolls JK, Fan S and Chen K: Epigenetic regulation of IL-17-induced chemokines in lung epithelial cells. Mediators Inflamm. 2019(9050965)2019.PubMed/NCBI View Article : Google Scholar | |
Lei L, Zhao C, Qin F, He ZY, Wang X and Zhong XN: Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis. Clin Exp Rheumatol. 34 (Suppl 100):S14–S22. 2016.PubMed/NCBI | |
Gouda MM and Bhandary YP: Acute lung injury: IL-17A-mediated inflammatory pathway and its regulation by curcumin. Inflammation. 42:1160–1169. 2019.PubMed/NCBI View Article : Google Scholar | |
Roos AB, Mori M, Gura HK, Lorentz A, Bjermer L, Hoffmann HJ, Erjefält JS and Stampfli MR: Increased IL-17RA and IL-17RC in end-stage COPD and the contribution to mast cell secretion of FGF-2 and VEGF. Respir Res. 18(48)2017.PubMed/NCBI View Article : Google Scholar | |
Miossec P and Kolls JK: Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Discov. 11:763–776. 2012.PubMed/NCBI View Article : Google Scholar | |
Rex DAB, Dagamajalu S, Gouda MM, Suchitha GP, Chanderasekaran J, Raju R, Prasad TSK and Bhandary YP: A comprehensive network map of IL-17A signaling pathway. J Cell Commun Signal. 17:209–215. 2023.PubMed/NCBI View Article : Google Scholar | |
Schmidt T, Luebbe J, Kilian C, Riedel JH, Hiekmann S, Asada N, Ginsberg P, Robben L, Song N, Kaffke A, et al: IL-17 receptor C signaling controls CD4+ TH17 immune responses and tissue injury in immune-mediated kidney diseases. J Am Soc Nephrol. 32:3081–3098. 2021.PubMed/NCBI View Article : Google Scholar | |
He F, Yu X, Zhang J, Cui J, Tang L, Zou S, Pu J and Ran P: Biomass-related PM2.5 induced inflammatory microenvironment via IL-17F/IL-17RC axis. Environ Pollut. 342(123048)2024.PubMed/NCBI View Article : Google Scholar | |
Ni Q, Li G, Chen Y, Bao C, Wang T, Li Y, Ruan X, Wang H and Sun W: LECs regulate neutrophil clearance through IL-17RC/CMTM4/NF-κB axis at sites of inflammation or infection. Mucosal Immunol. 17:723–738. 2024.PubMed/NCBI View Article : Google Scholar | |
Park SJ, Hahn HJ, Oh SR and Lee HJ: Theophylline attenuates BLM-induced pulmonary fibrosis by inhibiting Th17 differentiation. Int J Mol Sci. 24(1019)2023.PubMed/NCBI View Article : Google Scholar | |
Maxwell JR, Yadav R, Rossi RJ, Ruby CE, Weinberg AD, Aguila HL and Vella AT: IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol. 177:234–245. 2006.PubMed/NCBI View Article : Google Scholar | |
Shao XF, Li B, Shen J, Wang QF, Chen SS, Jiang XC and Qiang D: Ghrelin alleviates traumatic brain injury-induced acute lung injury through pyroptosis/NF-κB pathway. Int Immunopharmacol. 79(106175)2020.PubMed/NCBI View Article : Google Scholar | |
Kobori T, Hamasaki S, Kitaura A, Yamazaki Y, Nishinaka T, Niwa A, Nakao S, Wake H, Mori S, Yoshino T, et al: Interleukin-18 amplifies macrophage polarization and morphological alteration, leading to excessive angiogenesis. Front Immunol. 9(334)2018.PubMed/NCBI View Article : Google Scholar | |
Cai G, Lu Y, Zhong W, Wang T, Li Y, Ruan X, Chen H, Sun L, Guan Z, Li G, et al: Piezo1-mediated M2 macrophage mechanotransduction enhances bone formation through secretion and activation of transforming growth factor-β1. Cell Prolif. 56(e13440)2023.PubMed/NCBI View Article : Google Scholar | |
Zhang C, Zhu X, Hua Y, Zhao Q, Wang K, Zhen L, Wang G, Lü J, Luo A, Cho WC, et al: YY1 mediates TGF-β1-induced EMT and pro-fibrogenesis in alveolar epithelial cells. Respir Res. 20(249)2019.PubMed/NCBI View Article : Google Scholar | |
Ibi M, Horie S, Kyakumoto S, Chosa N, Yoshida M, Kamo M, Ohtsuka M and Ishisaki A: Cell-cell interactions between monocytes/macrophages and synoviocyte-like cells promote inflammatory cell infiltration mediated by augmentation of MCP-1 production in temporomandibular joint. Biosci Rep. 38(BSR20171217)2018.PubMed/NCBI View Article : Google Scholar | |
Wu L, Pu L and Zhuang Z: miR-155-5p/FOXO3a promotes pulmonary fibrosis in rats by mediating NLRP3 inflammasome activation. Immunopharmacol Immunotoxicol. 45:257–267. 2023.PubMed/NCBI View Article : Google Scholar | |
Schinocca C, Rizzo C, Fasano S, Grasso G, La Barbera L, Ciccia F and Guggino G: Role of the IL-23/IL-17 pathway in rheumatic diseases: An overview. Front Immunol. 12(637829)2021.PubMed/NCBI View Article : Google Scholar | |
Zhang Q, Tong L, Wang B, Wang T and Ma H: Diagnostic value of serum levels of IL-22, IL-23, and il-17 for idiopathic pulmonary fibrosis associated with lung cancer. Ther Clin Risk Manag. 18:429–437. 2022.PubMed/NCBI View Article : Google Scholar | |
Bhattacharya G, Sengupta S, Jha R, Shaw SK, Jogdand GM, Barink PK, Padhan P, Parida JR and Devadas S: IL-21/23 axis modulates inflammatory cytokines and RANKL expression in RA CD4+ T cells via p-Akt1 signaling. Front Immunol. 14(1235514)2023.PubMed/NCBI View Article : Google Scholar | |
Loo WJ, Turchin I, Prajapati VH, Gooderham MJ, Grewal P, Hong CH, Sauder M, Vender RB, Maari C and Papp KA: Clinical implications of targeting the JAK-STAT pathway in psoriatic disease: Emphasis on the TYK2 pathway. J Cutan Med Surg. 27 (1 Suppl):3S–24S. 2023.PubMed/NCBI View Article : Google Scholar | |
Vuyyuru SK, Shackelton LM, Hanzel J, Ma C, Jairath V and Feagan BG: Targeting IL-23 for IBD: Rationale and progress to date. Drugs. 83:873–891. 2023.PubMed/NCBI View Article : Google Scholar | |
Ogishi M, Arias AA, Yang R, Han JE, Zhang P, Rinchai D, Halpern J, Mulwa J, Keating N, Chrabieh M, et al: Impaired IL-23-dependent induction of IFN-γ underlies mycobacterial disease in patients with inherited TYK2 deficiency. J Exp Med. 219(e20220094)2022.PubMed/NCBI View Article : Google Scholar | |
Senoo S, Taniguchi A, Itano J, Oda N, Morichika D, Fujii U, Guo L, Sunami R, Kanehiro A, Tokioka F, et al: Essential role of IL-23 in the development of acute exacerbation of pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 321:L925–L940. 2021.PubMed/NCBI View Article : Google Scholar | |
Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie ANJ and Lee RT: IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest. 117:1538–1549. 2007.PubMed/NCBI View Article : Google Scholar | |
Piyadasa H, Lloyd D, Lee AHY, Altieri A, Hemshekhar M, Osawa N, Basu S, Blimkie T, Falsafi R, Halayko AJ, et al: Characterization of immune responses and the lung transcriptome in a murine model of IL-33 challenge. Biochim Biophys Acta Mol Basis Dis. 1866(165950)2020.PubMed/NCBI View Article : Google Scholar | |
Drake LY and Kita H: IL-33: Biological properties, functions, and roles in airway disease. Immunol Rev. 278:173–184. 2017.PubMed/NCBI View Article : Google Scholar | |
Chen YL, Gutowska-Owsiak D, Hardman CS, Westmoreland M, MacKenzie T, Cifuentes L, Waithe D, Lloyd-Lavery A, Marquette A, Londei M and Ogg C: Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis. Sci Transl Med. 11(eaax2945)2019.PubMed/NCBI View Article : Google Scholar | |
Kosloski MP, Kalliolias GD, Xu CR, Harel S, Lai CH, Zheng W, Davis JD and Kamal MA: Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first-in-human and first-in-patient trials. Clin Transl Sci. 15:384–395. 2022.PubMed/NCBI View Article : Google Scholar | |
She YX, Yu QY and Tang XX: Role of interleukins in the pathogenesis of pulmonary fibrosis. Cell Death Discov. 7(52)2021.PubMed/NCBI View Article : Google Scholar | |
Jayalatha AS, Hesse L, Ketelaar ME, Koppelman GH and Nawijn MC: The central role of IL-33/IL-1RL1 pathway in asthma: From pathogenesis to intervention. Pharmacol Ther. 225(107847)2021.PubMed/NCBI View Article : Google Scholar | |
Nechama M, Kwon J, Wei S, Kyi AT, Welner RS, Ben-Dov IZ, Arredouani MS, Asara JM, Chen CH, Tsai CY, et al: The IL-33-PIN1-IRAK-M axis is critical for type 2 immunity in IL-33-induced allergic airway inflammation. Nat Commun. 9(1603)2018.PubMed/NCBI View Article : Google Scholar | |
Reid F, Singh D, Albayaty M, Moate R, Jimenez E, Sadiq MW, Howe D, Gavala M, Killick H, Williams A, et al: A randomized phase I study of the anti-interleukin-33 antibody Tozorakimab in healthy adults and patients with chronic obstructive pulmonary disease. Clin Pharmacol Ther. 115:565–575. 2024.PubMed/NCBI View Article : Google Scholar | |
Catalan-Dibene J, McIntyre LL and Zlotnik A: Interleukin 30 to interleukin 40. J Interferon Cytokine Res. 38:423–439. 2018.PubMed/NCBI View Article : Google Scholar | |
Borthwick LA: The IL-1 cytokine family and its role in inflammation and fibrosis in the lung. Semin Immunopathol. 38:517–534. 2016.PubMed/NCBI View Article : Google Scholar | |
Andoh A and Nishida A: Pro- and anti-inflammatory roles of interleukin (IL)-33, IL-36, and IL-38 in inflammatory bowel disease. J Gastroenterol. 58:69–78. 2023.PubMed/NCBI View Article : Google Scholar | |
Aoyagi T, Newstead MW, Zeng XY, Kunkel SL, Kaku M and Standiford TJ: IL-36 receptor deletion attenuates lung injury and decreases mortality in murine influenza pneumonia. Mucosal Immunol. 10:1043–1055. 2017.PubMed/NCBI View Article : Google Scholar | |
Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, Rodriguez E, Ronchi F, Sallusto F, Dinh H, Sims JE and Gabay C: IL-36R ligands are potent regulators of dendritic and T cells. Blood. 118:5813–5823. 2011.PubMed/NCBI View Article : Google Scholar | |
Cao J, Liu JH, Wise SG, Fan J, Bao S and Zheng GS: The role of IL-36 and 37 in hepatocellular carcinoma. Front Immunol. 15(1281121)2024.PubMed/NCBI View Article : Google Scholar | |
Elias M, Zhao S, Le HT, Wang J, Neurath MF, Neufert C, Fiocchi C and Rieder F: IL-36 in chronic inflammation and fibrosis-bridging the gap? J Clin Invest. 131(144336)2021.PubMed/NCBI View Article : Google Scholar | |
Montero-Blay A, Blanco JD, Rodriguez-Arce I, Lastrucci C, Piñero-Lambea C, Lluch-Senar M and Serrano L: Bacterial expression of a designed single-chain IL-10 prevents severe lung inflammation. Mol Syst Biol. 19(e11037)2023.PubMed/NCBI View Article : Google Scholar | |
Huaux F: Interpreting immunoregulation in lung fibrosis: A new branch of the immune model. Front Immunol. 12(690375)2021.PubMed/NCBI View Article : Google Scholar | |
Gabryšová L, Howes A, Saraiva M and O'Garra A: The regulation of IL-10 expression. Curr Top Microbiol Immunol. 380:157–190. 2014.PubMed/NCBI View Article : Google Scholar | |
Saraiva M, Vieira P and O'garra A: Biology and therapeutic potential of interleukin-10. J Exp Med. 217(e20190418)2020.PubMed/NCBI View Article : Google Scholar | |
Chlastáková A, Kaščáková B, Kotál J, Langhansová H, Kotsyfakis M, Kutá Smatanová I, Tirloni L and Chmelař J: Iripin-1, a new anti-inflammatory tick serpin, inhibits leukocyte recruitment in vivo while altering the levels of chemokines and adhesion molecules. Front Immunol. 14(1116324)2023.PubMed/NCBI View Article : Google Scholar | |
Neumann C, Scheffold A and Rutz S: Functions and regulation of T cell-derived interleukin-10. Semin Immunol. 44(101344)2019.PubMed/NCBI View Article : Google Scholar | |
Zhang N, Li P, Lin H, Shuo T, Ping F, Su L and Chen G: IL-10 ameliorates PM2.5-induced lung injury by activating the AMPK/SIRT1/PGC-1α pathway. Environ Toxicol Pharmacol. 86(103659)2021.PubMed/NCBI View Article : Google Scholar | |
Jia Q, Wen J, Yang Q, Liu S, Zhang J, Wang T and Cheng Y: Lonicera japonica Thunb extract ameliorates lipopolysaccharide-induced acute lung injury associated with luteolin-mediated suppression of NF-κB signaling pathway. J Inflamm (Lond). 20(44)2023.PubMed/NCBI View Article : Google Scholar | |
Boonyatecha N, Sangphech N, Wongchana W, Kueanjinda P and Palaga T: Involvement of Notch signaling pathway in regulating IL-12 expression via c-Rel in activated macrophages. Mol Immunol. 51:255–262. 2012.PubMed/NCBI View Article : Google Scholar | |
Utsunomiya T, Mimura-Kimura Y, Yamamoto T, Aoe K, Oishi K, Kamei H, Matsunaga K, Yano M and Mimura Y: Cytokine adsorption to polymyxin B-immobilized fiber: An in vitro study. Blood Purif. 50:230–237. 2021.PubMed/NCBI View Article : Google Scholar | |
Zhou L, Tian H, Wang Q, Xiong W, Zhou X and Yan J: Effect of Qingfei Huaxian Decoction combined with prednisone acetate on serum inflammatory factors and pulmonary function of patients with idiopathic pulmonary fibrosis. Am J Transl Res. 14:5905–5914. 2022.PubMed/NCBI | |
Kotani T, Masutani R, Suzuka T, Oda K, Makino S and Ii M: Anti-inflammatory and anti-fibrotic effects of intravenous adipose-derived stem cell transplantation in a mouse model of bleomycin-induced interstitial pneumonia. Sci Rep. 7(14608)2017.PubMed/NCBI View Article : Google Scholar | |
Bao L, Hao CF, Liu SN, Zhang L, Wang J, Wang D, Li YP and Yao W: Dendritic cells trigger imbalance of Th1/Th2 cells in silica dust exposure rat model via MHC-II, CD80, CD86 and IL-12. RSC Adv. 8:26108–26115. 2018.PubMed/NCBI View Article : Google Scholar | |
Keane MP, Belperio JA, Burdick MD and Strieter RM: IL-12 attenuates bleomycin-induced pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 281:L92–L97. 2001.PubMed/NCBI View Article : Google Scholar | |
Nie Y, Yang B, Hu J, Zhang L and Ma Z: Bruceine D ameliorates the balance of Th1/Th2 in a mouse model of ovalbumin-induced allergic asthma via inhibiting the NOTCH pathway. Allergol Immunopathol (Madr). 49:73–79. 2021.PubMed/NCBI View Article : Google Scholar | |
Kikuchi N, Ishii Y, Morishima Y, Yageta Y, Haraguchi N, Itoh K, Yamamoto M and Hizawa N: Nrf2 protects against pulmonary fibrosis by regulating the lung oxidant level and Th1/Th2 balance. Respir Res. 11(31)2010.PubMed/NCBI View Article : Google Scholar | |
Huaux F, Lardot C, Arras M, Delos M, Many MC, Coutelier JP, Buchet JP, Renauld JC and Lison D: Lung fibrosis induced by silica particles in NMRI mice is associated with an upregulation of the p40 subunit of interleukin-12 and Th-2 manifestations. Am J Respir Cell Mol Biol. 20:561–672. 1999.PubMed/NCBI View Article : Google Scholar | |
Wang XY, Liu DY, Zhang XH, Yang LM, Xia ZY and Zhang QF: Exosomes from adipose-derived mesenchymal stem cells alleviate sepsis-induced lung injury in mice by inhibiting the secretion of IL-27 in macrophages. Cell Death Discov. 8(18)2022.PubMed/NCBI View Article : Google Scholar | |
Chen Y, Zhu M, Hu J, He S, Li S, Liu B and Yang J: IL-27 alleviates airway inflammation and airway hyperresponsiveness in asthmatic mice by targeting the CD39/ATP axis of dendritic cells. Inflammation. 47:807–821. 2024.PubMed/NCBI View Article : Google Scholar | |
Dong Z, Zhao X, Tai W, Lei W, Wang Y, Li Z and Zhang T: IL-27 attenuates the TGF-β1-induced proliferation, differentiation and collagen synthesis in lung fibroblasts. Life Sci. 146:24–33. 2016.PubMed/NCBI View Article : Google Scholar | |
Dong Z, Tai W, Lei W, Wang Y, Li Z and Zhang T: IL-27 inhibits the TGF-β1-induced epithelial-mesenchymal transition in alveolar epithelial cells. BMC Cell Biol. 17(7)2016.PubMed/NCBI View Article : Google Scholar | |
Ting L, Feng Y, Zhou Y, Tong Z and Dong Z: IL-27 induces autophagy through regulation of the DNMT1/lncRNA MEG3/ERK/p38 axis to reduce pulmonary fibrosis. Respir Res. 24(67)2023.PubMed/NCBI View Article : Google Scholar | |
Riehl DR, Sharma A, Roewe J, Murke F, Ruppert C, Eming SA, Bopp T, Kleinert H, Radsak MP, Colucci G, et al: Externalized histones fuel pulmonary fibrosis via a platelet-macrophage circuit of TGFβ1 and IL-27. Proc Natl Acad Sci USA. 120(e2215421120)2023.PubMed/NCBI View Article : Google Scholar | |
Dinarello CA and Bufler P: Interleukin-37. Semin Immunol. 25:466–468. 2013.PubMed/NCBI View Article : Google Scholar | |
Kim SK, Choe JY, Kim JW, Park KY and Kim B: Anti-inflammatory effect of atorvastatin and rosuvastatin on monosodium urate-induced inflammation through IL-37/Smad3-complex activation in an in vitro study using THP-1 macrophages. Pharmaceuticals (Basel). 17(883)2024.PubMed/NCBI View Article : Google Scholar | |
Luo C, Shu Y, Luo J, Liu D, Huang DS, Han Y, Chen C, Li YC, Zou JM, Qin J, et al: Intracellular IL-37b interacts with Smad3 to suppress multiple signaling pathways and the metastatic phenotype of tumor cells. Oncogene. 36:2889–2899. 2017.PubMed/NCBI View Article : Google Scholar | |
Conti P, Caraffa A, Gallenga CE, Ross R, Kritas SK, Frydas I, Younes A, Di Emidio P, Ronconi G and Pandolfi F: Powerful anti-inflammatory action of luteolin: Potential increase with IL-38. Biofactors. 47:165–169. 2021.PubMed/NCBI View Article : Google Scholar | |
Diaz-Barreiro A, Huard A and Palmer G: Multifaceted roles of IL-38 in inflammation and cancer. Cytokine. 151(155808)2022.PubMed/NCBI View Article : Google Scholar | |
Chen W, Xi S, Ke Y and Lei Y: The emerging role of IL-38 in diseases: A comprehensive review. Immun Inflamm Dis. 11(e991)2023.PubMed/NCBI View Article : Google Scholar | |
van de Veerdonk FL, de Graaf DM, Joosten LA and Dinarello CA: Biology of IL-38 and its role in disease. Immunol Rev. 281:191–196. 2018.PubMed/NCBI View Article : Google Scholar | |
Xu Z, Yuan X, Gao Q, Li Y and Li M: Interleukin-38 overexpression prevents bleomycin-induced mouse pulmonary fibrosis. Naunyn Schmiedebergs Arch Pharmacol. 394:391–399. 2021.PubMed/NCBI View Article : Google Scholar | |
Kelly-Welch A, Hanson EM and Keegan AD: Interleukin-4 (IL-4) pathway. Sci STKE. 2005(cm9)2005.PubMed/NCBI View Article : Google Scholar | |
Rao LZ, Wang Y, Zhang L, Wu G, Zhang L, Wang FX, Chen LM, Sun F, Jia S, Zhang S, et al: IL-24 deficiency protects mice against bleomycin-induced pulmonary fibrosis by repressing IL-4-induced M2 program in macrophages. Cell Death Differ. 28:1270–1283. 2021.PubMed/NCBI View Article : Google Scholar | |
Sterclova M, Kishore A, Sikorova K, Skibova J, Petrek M and Vasakova M: Effect of genotype on the disease course in idiopathic pulmonary fibrosis despite antifibrotic treatment. Biomed Rep. 15(87)2021.PubMed/NCBI View Article : Google Scholar | |
Singh B, Kasam RK, Sontake V, Wynn TA and Madala SK: Repetitive intradermal bleomycin injections evoke T-helper cell 2 cytokine-driven pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol. 313:L796–L806. 2017.PubMed/NCBI View Article : Google Scholar | |
Mattoo H, Bangari DS, Cummings S, Humulock Z, Habiel D, Xu EY, Pate N, Resnick R, Savova V, Qian G, et al: Molecular features and stages of pulmonary fibrosis driven by type 2 inflammation. Am J Respir Cell Mol Biol. 69:404–421. 2023.PubMed/NCBI View Article : Google Scholar | |
Khansalar S, Faghih Z, Barani S, Kalani M, Ataollahi MR, Mohammadi Z, Namdari S and Kalantar K: IFN-γ, IL-17, IL-22+ CD4+ subset in patients with hepatitis C virus and correlation with clinical factor. Am J Clin Exp Immunol. 13:43–52. 2024.PubMed/NCBI View Article : Google Scholar | |
Liang M, Wang J, Chu H, Zhu X, He H, Liu Q, Qiu J, Zhou X, Guan M, Xue Y, et al: Interleukin-22 inhibits bleomycin-induced pulmonary fibrosis. Mediators Inflamm. 2013(209179)2013.PubMed/NCBI View Article : Google Scholar | |
Bao A, Ma E, Cornman H, Kambala A, Manjunath J, Kollhoff AL, Imo BU, Kwatra MM and Kwatra SG: Dupilumab therapy modulates circulating inflammatory mediators in patients with prurigo nodularis. JID Innov. 4(100281)2024.PubMed/NCBI View Article : Google Scholar | |
Liu J, Huang Y, Liu N, Qiu H, Zhang X, Liu X, He M, Chen M and Huang S: The imbalance of pulmonary Th17/Treg cells in BALB/c suckling mice infected with respiratory syncytial virus-mediated intestinal immune damage and gut microbiota changes. Microbiol Spectr. 12(e0328323)2024.PubMed/NCBI View Article : Google Scholar | |
Li C, Liu M, Deng L, Luo D, Ma R and Lu Q: Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways. Phytomedicine. 116(154899)2023.PubMed/NCBI View Article : Google Scholar | |
Zhang J, Wang W, Liang S, Zhou X, Rekha RS, Gudmundsson GH, Bergman P, Ai Q, Mai K and Wan M: Butyrate induces STAT3/HIF-1α/IL-22 signaling via GPCR and HDAC3 inhibition to activate autophagy in head kidney macrophages from turbot (Scophthalmus maximus L.). Fish Shellfish Immunol. 143(109214)2023.PubMed/NCBI View Article : Google Scholar | |
Sajiir H, Keshvari S, Wong KY, Borg DJ, Steyn FJ, Fercher C, Taylor K, Taylor B, Barnard RT, Müller A, et al: Liver and pancreatic-targeted interleukin-22 as a therapeutic for metabolic dysfunction-associated steatohepatitis. Nat Commun. 15(4528)2024.PubMed/NCBI View Article : Google Scholar | |
Kamata K, Hara A, Minaga K, Yoshikawa T, Kurimoto M, Sekai I, Okai N, Omaru N, Masuta Y, Otsuka Y, et al: Activation of the aryl hydrocarbon receptor inhibits the development of experimental autoimmune pancreatitis through IL-22-mediated signaling pathways. Clin Exp Immunol. 212:171–183. 2023.PubMed/NCBI View Article : Google Scholar | |
Zhang Z, Chakawa MB, Galeas-Pena M, Frydman JA, Allen MJ, Jones M and Pociask D: IL-22 binding protein controls IL-22-driven bleomycin-induced lung injury. Am J Pathol. 194:338–352. 2024.PubMed/NCBI View Article : Google Scholar | |
Goulart A, Boko MMM, Martins NS, Gembre AF, de Oliveira RS, Palma-Albornoz SP, Bertolini T, Ribolla PEM, Ramalho LNZ, Fraga-Silva TFC and Bonato VLD: IL-22 is deleterious along with IL-17 in allergic asthma but is not detrimental in the comorbidity asthma and acute pneumonia. Int J Mol Sci. 24(10418)2023.PubMed/NCBI View Article : Google Scholar | |
He G, Lang Y, Zhao S, Wang X and Ouyang Y: Advances in the role of interleukin-22 in airway remodeling in asthma. J Pract Med. 38:2491–2494. 2022. | |
Nikoopour E, Bellemore SM and Singh B: IL-22, cell regeneration and autoimmunity. Cytokine. 74:35–42. 2015.PubMed/NCBI View Article : Google Scholar | |
Zindl CL, Wilson CG, Chadha AS, Duck LW, Cai B, Harbour SN, Nagaoka-Kamata Y, Hatton RD, Gao M, Figge DA and Weaver CT: Distal colonocytes targeted by C. rodentium recruit T-cell help for barrier defence. Nature. 629:669–678. 2024.PubMed/NCBI View Article : Google Scholar | |
Whittington HA, Armstrong L, Uppington KM and Millar AB: Interleukin-22: A potential immunomodulatory molecule in the lung. Am J Respir Cell Mol Biol. 31:220–226. 2004.PubMed/NCBI View Article : Google Scholar | |
Zhang C, Tang S, Zong X, Duan L and Wang YF: Anti- IL-22 neutralizing antibodies decrease inflammation lesions and reduce mortality in enterovirus 71-infected mice. Cell Mol Biol (Noisy-le-grand). 69:254–258. 2023.PubMed/NCBI View Article : Google Scholar | |
Qu Z, Dou W, Zhang K, Duan L, Zhou D and Yin S: IL-22 inhibits bleomycin-induced pulmonary fibrosis in association with inhibition of IL-17A in mice. Arthritis Res Ther. 24(280)2022.PubMed/NCBI View Article : Google Scholar | |
Gu P, Wang D, Zhang J, Wang X, Chen Z, Gu L, Liu M, Meng F, Yang J, Cai H, et al: Protective function of interleukin-22 in pulmonary fibrosis. Clin Transl Med. 11(e509)2021.PubMed/NCBI View Article : Google Scholar | |
Fang S, Ju DW, Lin Y and Chen W: The role of interleukin-22 in lung health and its therapeutic potential for COVID-19. Front Immunol. 13(951107)2022.PubMed/NCBI View Article : Google Scholar | |
Fang Q, Xie J, Zong J, Zhou Y, Zhou Q, Yin S, Cao L, Yin H and Zhou D: Expression and diagnostic value of interleukin-22 in rheumatoid arthritis-associated interstitial lung disease. Int Immunopharmacol. 134(112173)2024.PubMed/NCBI View Article : Google Scholar | |
Wu Y, Min J, Ge C, Shu JP, Tian D, Yuan Y and Zhou D: Interleukin 22 in liver injury, inflammation and cancer. Int J Biol Sci. 16(2405)2020.PubMed/NCBI View Article : Google Scholar | |
Beppu AK, Zhao J, Yao C, Carraro G, Israely E, Coelho AL, Drake K, Hogaboam CM, Parks WC, Kolls JK and Stripp BR: Epithelial plasticity and innate immune activation promote lung tissue remodeling following respiratory viral infection. Nat Commun. 14(5814)2023.PubMed/NCBI View Article : Google Scholar |